Physician profile
Brad Denney
NPI 1962663229
$20,739.78
in general payments reported to CMS, 2019-2025
17 companies · $2,700 in 2025
The $2,700 reported for 2025 was more than what 87% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $155 · 2021: $2,570 · 2022: $7,520 · 2023: $5,135 · 2024: $1,772 · 2025: $2,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,539 · Food and Beverage: $3,567 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,539.00 |
| Food and Beverage | $3,566.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $11,896.29 | 2022-2025 | Ecm Patch,Pouch |
| Rti Surgical, INC | $4,134.82 | 2021-2023 | |
| Mentor Worldwide LLC | $1,203.87 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Allergan, INC. | $872.61 | 2019-2022 | |
| Integra Lifesciences Corporation | $791.46 | 2023-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Abbvie INC. | $439.15 | 2024-2025 | |
| Avita Medical Americas, LLC | $317.51 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Tela Bio, INC. | $291.05 | 2024 | Ovitex 2s |
| Access Pro Medical, LLC | $175.03 | 2025 | Matriderm |
| Innovation Technologies INC | $157.52 | 2021 | |
| Motiva USA, LLC | $154.52 | 2025 | |
| Acell, INC. | $122.61 | 2019 | |
| Smith+Nephew, INC. | $106.99 | 2024 | Stravix, Grafix Pl, Renasys Touch |
| W. L. Gore & Associates, INC. | $27.88 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Baxter Healthcare | $19.83 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $15.03 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Denney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.